See also this year's filing and all EDGAR filings for this company.
PDF Report 0001169245_2019_Phasebio_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001169245, Phasebio Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 62,628,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 355,000 |
| 3 | remainder_Assets | 43,000 |
| 4 | LiabilitiesCurrent | 4,577,000 |
| 5 | LiabilitiesNoncurrent | 7,500,000 |
| 6 | remainder_Liabilities | 22,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,857,000 |
| 9 | ResearchAndDevelopmentExpense | 15,455,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 668,000 |
| 12 | remainder_NetIncome | -4,202,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,026,000 |
| 1 | Liabilities | 12,099,000 |
| 2 | Expenses | 20,312,000 |
| 3 | Revenues | 668,000 |
| 4 | StockholdersEquity | 50,927,000 |
| 5 | NetIncome | -23,846,000 |
| 6 | ComprehensiveNetIncome | -23,846,000 |
| 7 | BaseVar | 50,153,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.32 |
| 9 | EconomicCapitalRatio | 3.24 |
Edgar->Model Mapping
Feature Distribution
